Plain-English translation of NCT05486455 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is evaluating how well low-dose CT scans work at detecting early lung cancer in people who smoke or used to smoke. Researchers will use a standardized classification system to interpret the scan results and assess the accuracy and usefulness of this screening approach for smokers.
Lung cancer is often detected late in current and former smokers, when it's harder to treat. This study aims to understand whether regular CT screening can catch lung cancer earlier, when treatment is more effective.
You likely qualify if…
You likely don't qualify if…
You will have a low-dose CT scan of your chest, which is a painless imaging test that takes about 10–15 minutes. The scan images will be reviewed and classified using a standard system to look for any signs of lung cancer or nodules that need monitoring. The study does not involve medication or invasive procedures—only the single imaging test.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
France
Enrollment target
~1,000 participants
Started
November 2022
Primary completion
October 2028
Age range
50 Years – 80 Years
Last updated on clinicaltrials.gov in December 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cecile Bielmann
Hopital Saint Joseph Marseille
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.